Company profile

AI Diagnostics (Pty) Ltd

AI Diagnostics (Pty) Ltd is a South Africa-based medtech company specialising in artificial intelligence-enabled diagnostic devices for tuberculosis screening. Founded in 2020 and headquartered in Cape Town, the company develops and commercialises the Ostium digital stethoscope, paired with proprietary AI software (AI.TB) that detects TB through acoustic lung sound analysis. The company targets community health workers, nurses, and pharmacists in South Africa, Sub-Saharan Africa, and Asia as primary users. AI Diagnostics operates as a privately held medtech enterprise with regulatory approval from the South African Health Products Regulatory Authority (SAHPRA). As of April 2026, the company had screened over 1,000 patients in South Africa and was conducting clinical research across more than 10 countries in Africa and Asia. The company raised ZAR 85 million (~USD 5 million) in a pre-Series A funding round led by The Steele Foundation for Hope, with participation from iFSP Group and Global Innovation Fund.

Sector

Healthcare / Medical Equipment, Digital Health Platforms

Markets

South Africa

Founded

2020

Ownership

Private

Stage

Startup

Capital raised

$5.2m

Employees

11-50

Business model

B2B, B2B2C Transactional, Licensing, Manufacturing

Products and services

Ostium Digital Stethoscope, AI.TB (Tuberculosis Detection AI Model) & AID.APP (Companion Diagnostic Application)

Source: Partner Researchers.